Alfred Siegfried

Doctor of Medicine,  Cleveland Clinic 

Location: United States

Consulting Services

Case Consulting Biostatistics Journal Manuscript

Areas Of Interest

Models, Biobehavioral GLAST 1 Glutamate Aspartate Transporter Gastrointestinal Tuberculosis Joint Ventures, Hospital-Physician Carbon 13 Magnetic Resonance Spectroscopy Cardiac Rehabilitation Cell Cycle-Transition Points Meta cognitive Awareness Mice, Inbred SENCAR beta-Crystallin, A Subunit Lippias Dissociative Amnesias Orbitofrontal Regions Cysts, Hepatic Hydatid Tests, Serological Method, Life Table Jagged Proteins Metoclopramide Hydrochloride Long Acting Insulin Medial Amygdaloid Nucleus Disulfide Isomerase, Protein Culture, Beauty Primula veris Actinobacillus Infections Aneurysm, Miliary Narrative Therapy Endothelioma, Lymphatic T Virus Speech Delays Brain Injuries, Traumatic

Professional Narrative

Dr. Alfred Siegfried was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Siegfried has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Medical Writer, Harvard Med 2001
Director Medicine, Mayo Clinic 2013

Education

Bachelor of science in nursing, Baylor College 1988
Doctor of medicine, Harvard Medical School 2004

Referees


Publications

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :